Skip to main content
VCbacked
Log inGet Started

Apeximmune Therapeutics

Burlingame, United States

Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.

$21.3M raised
Mar 2025
Series A
BiotechnologyHealth DiagnosticsLife Science

Top Investors

PharmaEssentiaDCI PartnersTaya Venture CapitalHuahai USHercules Bioventure Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Apeximmune Therapeutics

How much funding has Apeximmune Therapeutics raised?
Apeximmune Therapeutics has raised $21.3M in total funding. The most recent round was Series A. The last funding was announced in March 2025.
Who are Apeximmune Therapeutics's investors?
Apeximmune Therapeutics's investors include PharmaEssentia, DCI Partners, Taya Venture Capital, Huahai US, Hercules Bioventure Partners.
Where is Apeximmune Therapeutics headquartered?
Apeximmune Therapeutics is headquartered in Burlingame, United States.
What does Apeximmune Therapeutics do?
Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.
What stage is Apeximmune Therapeutics at?
Apeximmune Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Apeximmune Therapeutics — Funding & Investors." VCBacked, March 31, 2025, https://www.vcbacked.co/company/apeximmune-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2025). Apeximmune Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/apeximmune-therapeutics
Wikipedia (cite web)
{{cite web |title=Apeximmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/apeximmune-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K